We are live on ! Find out more
NP

NorthRock Partners Portfolio holdings

AUM $6.89B
1-Year Est. Return 19.83%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+19.83%
3 Year Est. Return
+62.84%
5 Year Est. Return
+74.26%
10 Year Est. Return
+264.52%
AUM
$1.22B
AUM Growth
+$26.2M
Cap. Flow
+$8.76M
Cap. Flow %
0.72%
Top 10 Hldgs %
64.43%
Holding
295
New
37
Increased
143
Reduced
77
Closed
13

Top Buys

Rank Stock Value
1
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$12.7M
2
ESTA icon
Establishment Labs
ESTA
+$2.87M
3
MSFT icon
Microsoft
MSFT
+$2.19M
4
AMZN icon
Amazon
AMZN
+$2.02M
5
AAPL icon
Apple
AAPL
+$2.02M

Sector Composition

Rank Sector Weight
1 Miscellaneous 65.76%
2 Consumer Staples 11.33%
3 Technology 8.86%
4 Financials 4.06%
5 Healthcare 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
151
CVS Health
CVS
$117B
$552K 0.05%
6,502
+1,642
+34% +$138K
IBB icon
152
iShares Biotechnology ETF
IBB
$10.3B
$552K 0.05%
3,317
-130
-4% -$21.9K
KMB icon
153
Kimberly-Clark
KMB
$32.6B
$543K 0.04%
3,957
+442
+13% +$60.1K
VOT icon
154
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.8B
$524K 0.04%
2,218
+1
+0% +$242
FANG icon
155
Diamondback Energy
FANG
$54.5B
$522K 0.04%
5,509
+143
+3% +$11.5K
XLF icon
156
State Street Financial Select Sector SPDR ETF
XLF
$53.5B
$518K 0.04%
13,791
+1,540
+13% +$57.6K
XEL icon
157
Xcel Energy
XEL
$45.4B
$514K 0.04%
8,221
+3,082
+60% +$208K
F icon
158
Ford
F
$53.2B
$500K 0.04%
35,318
+12,053
+52% +$164K
IVW icon
159
iShares S&P 500 Growth ETF
IVW
$75.6B
$498K 0.04%
6,351
-593
-9% -$45.2K
MS icon
160
Morgan Stanley
MS
$318B
$496K 0.04%
4,834
+1,020
+27% +$101K
DUK icon
161
Duke Energy
DUK
$91.8B
$472K 0.04%
4,833
+708
+17% +$73.3K
OTTR icon
162
Otter Tail
OTTR
$3.74B
$470K 0.04%
8,403
-1,091
-11% -$57.8K
AMD icon
163
Advanced Micro Devices
AMD
$837B
$469K 0.04%
4,242
+1,431
+51% +$146K
VBK icon
164
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.7B
$465K 0.04%
1,658
-38
-2% -$10.9K
LMT icon
165
Lockheed Martin
LMT
$124B
$462K 0.04%
1,269
+120
+10% +$43.4K
MRSH
166
Marsh
MRSH
$84.4B
$445K 0.04%
2,937
+381
+15% +$57.6K
AZN icon
167
AstraZeneca
AZN
$253B
$444K 0.04%
3,701
+471
+15% +$54.8K
DOCU
168
DocuSign
DOCU
$13.2B
$443K 0.04%
1,719
+15
+0.9% +$4.32K
GILD icon
169
Gilead Sciences
GILD
$183B
$442K 0.04%
6,322
+1,009
+19% +$70.9K
NTGR icon
170
NETGEAR
NTGR
$618M
-11,519
Closed -$400K
VONG icon
171
Vanguard Russell 1000 Growth ETF
VONG
$45.1B
$438K 0.04%
6,209
-41
-0.7% -$2.98K
CCI icon
172
Crown Castle
CCI
$31.2B
$437K 0.04%
2,384
+415
+21% +$80.2K
OEF icon
173
iShares S&P 100 ETF
OEF
$20B
$437K 0.04%
2,215
-85
-4% -$17.3K
DE icon
174
Deere & Co
DE
$181B
$435K 0.04%
1,248
+183
+17% +$65.9K
PTPI
175
DELISTED
Petros Pharmaceuticals
PTPI
$431K 0.04%
461
-416
-47% -$270K

Similar funds

NorthRock Partners's Q3 2021 Portfolio in Review

As of Q3 2021, NorthRock Partners held 295 positions worth $1.22B, up 2.2% from $1.2B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

NorthRock Partners's Q3 2021 filing shows 37 new, 143 increased, 77 reduced and 13 closed positions. Its largest new stake was Stitch Fix: 15,784 shares worth $631K. The largest sale was Target, an estimated $20.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 66% of assets, down from 66% a quarter earlier, followed by Consumer Staples and Technology.

  • NorthRock Partners's largest Q3 2021 buy was Stitch Fix: 15,784 shares worth $631K.
  • NorthRock Partners added most to JPMorgan Ultra-Short Income ETF in Q3 2021, an estimated $12.7M increase.
  • NorthRock Partners's biggest Q3 2021 reduction was Target, cutting an estimated $20.2M.
  • NorthRock Partners fully exited Mandiant, Inc. Common Stock in Q3 2021, selling an estimated $704K.
  • NorthRock Partners's ten largest holdings make up 64% of its $1.22B portfolio in Q3 2021.
  • NorthRock Partners opened 37 new positions and closed 13 in Q3 2021.
  • NorthRock Partners's portfolio value rose 2.2% quarter-over-quarter to $1.22B.

Based on NorthRock Partners's 13F filing for Q3 2021, filed 12 Nov 2021.